Nasdaq Ktra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kintara Therapeutics (NASDAQ:KTRA – Get Free Report) and Pasithea Therapeutics (NASDAQ:KTTA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability. Earnings & Valuation This table compares Kintara […]

Kintara Therapeutics, Inc. (NASDAQ:KTRA – Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 83,900 shares, an increase of 126.1% from the October 15th total of 37,100 shares. Based on an average trading volume of 141,700 shares, […]

Kintara Therapeutics, Inc. (NASDAQ:KTRA – Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 14,700 shares, an increase of 53.1% from the September 15th total of 9,600 shares. Based on an average daily trading volume, of 16,600 […]

Kintara Therapeutics, Inc. (NASDAQ:KTRA – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 50,700 shares, a drop of 9.8% from the June 30th total of 56,200 shares. Based on an average trading volume of 176,100 shares, […]

Kintara Therapeutics, Inc. (NASDAQ:KTRA – Get Rating) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 22,200 shares, a decline of 12.9% from the March 31st total of 25,500 shares. Based on an average daily trading volume, of 25,900 shares, the days-to-cover ratio […]